Expert perspectives, research insights, and industry analysis from scientists, researchers, and leaders across pharma, biotech, and life sciences.
Recent breakthroughs in CRISPR-Cas9 delivery mechanisms have opened new frontiers in treating monogenic disorders, with clinical trials showing unprecedented precision in off-target reduction.
Dr. Sarah Mitchell
July 14, 2026
The shift to decentralized trial models has permanently altered patient recruitment strategies and data collection protocols, with regulatory bodies now providing clearer guidance on hybrid approaches.
James Okonkwo, PhD
July 10, 2026
Messenger RNA platforms are being rapidly adapted for oncology, rare diseases, and infectious disease prevention, with several candidates entering Phase II trials across multiple therapeutic areas.
Dr. Priya Nair
July 7, 2026
Machine learning models trained on multi-omics datasets are demonstrating remarkable accuracy in predicting drug-target interactions, compressing early discovery timelines significantly.
Marcus Chen
July 3, 2026
With the EU Packaging and Packaging Waste Regulation now in force, pharmaceutical manufacturers are accelerating the transition to recyclable and bio-based primary packaging materials.
Elena Vasquez
June 28, 2026
Global CDMO capacity constraints are forcing early-stage biotechs to rethink their manufacturing partnerships, with regional diversification emerging as a key risk mitigation strategy.
Dr. Aiden Walsh
June 24, 2026
Bispecific antibody platforms are gaining momentum in oncology pipelines, with multiple approvals expected in 2026 targeting hematological malignancies and solid tumors simultaneously.
Dr. Lena Hoffmann
June 20, 2026
Wearable-derived digital biomarkers are reshaping endpoint selection in clinical trials, enabling continuous, real-world data capture that traditional clinic visits cannot replicate.
Dr. Raj Patel
June 15, 2026
EMA and FDA are converging on harmonized frameworks for ATMPs including CAR-T, gene therapies, and tissue-engineered products, reducing approval timelines for breakthrough designations.
Sophie Laurent
June 10, 2026
Submit a guest post and reach thousands of pharma, biotech, and life sciences professionals. Our editorial team reviews all submissions within 5–7 business days.
Submit a Guest Post